BOMBSHELL review finds FDA using shoddy, junk science to fast-track drug approvals
(Natural News) The FDA is coming under fire after a study has found that they base drug approval decisions on low-quality research.
In response to criticism about the amount of time it takes for urgently needed drugs to be approved, the agency developed an “accelerated approval” procedure for drugs that treat serious conditions where few other options exist. This program allows medications that are desperately needed by patients to be approved using a lower standard than usual if it can be shown to be reasonably likely to benefit patients. Manufacturers must then carry out more rigorous follow-up studies within a period of three years to prove the drugs are effective.